Kenvue joins Murphy, other public officials to unveil 290,000 sq. ft. headquarters in Summit

Kenvue Inc. has taken the wraps off its new 290,000-square-foot global headquarters in Summit, with construction underway on a second facility as part of a revamped pharmaceutical campus.

JLL: Buyer wanted for 181,000 sq. ft. Bristol Myers lab, office facility in Warren

The owner of more than 181,000 square feet of high-end lab and office space in Warren has tapped JLL to sell the property, the longtime home of a major pharmaceutical company.

Onyx, JLL unveil redevelopment concepts and high-end office space at Summit campus

Onyx Equities and JLL have unveiled new plans and new possibilities for the sprawling former Celgene Corp. campus in Summit, where they’re now marketing two high-end office buildings and a redevelopment site at the heart of the nearly 640,000-square-foot property.

NKF inks sale of 181,000 sq. ft. R&D facility to Thor Equities

An investment firm has expanded its New Jersey life sciences portfolio with the acquisition of a research facility in Somerset County, in a transaction arranged by Newmark Knight Frank.

IN THE MOMENT: Investors Bank helps fund new Summit community center

A public- and private-sector alliance raised $6.5 million to renovate and modernize the Summit Community Center, which opened in 1954. Investors Bank, with the Investors Foundation, energized the fundraising and became the founding sponsor by providing a $250,000 grant.

JLL team provides a cure for New Jersey’s vacant pharma sites

Several of New Jersey’s largest, most prominent life sciences complexes are now on the path toward redevelopment, with new anchor tenants in place or new owners that can reclaim the value of what was left behind.

In the most high-profile cases, a team at JLL has been right in the thick of it.